| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.41B | 14.69B | 15.39B | 14.12B | 13.68B | 12.67B |
| Gross Profit | 959.00M | 928.00M | 1.03B | 807.00M | 826.00M | 592.00M |
| EBITDA | 434.00M | 697.00M | 776.00M | 644.00M | 2.13B | 119.00M |
| Net Income | -195.00M | 18.00M | 205.00M | -40.00M | 1.11B | -486.00M |
Balance Sheet | ||||||
| Total Assets | 8.84B | 9.35B | 9.42B | 9.16B | 10.76B | 10.26B |
| Cash, Cash Equivalents and Short-Term Investments | 860.00M | 945.00M | 1.11B | 947.00M | 1.52B | 1.69B |
| Total Debt | 2.39B | 2.40B | 2.54B | 2.58B | 3.70B | 4.31B |
| Total Liabilities | 6.68B | 6.82B | 6.82B | 6.74B | 7.80B | 8.68B |
| Stockholders Equity | 1.78B | 2.13B | 2.23B | 2.07B | 2.38B | 1.21B |
Cash Flow | ||||||
| Free Cash Flow | 261.00M | 277.00M | 415.00M | 47.00M | 0.00 | -80.00M |
| Operating Cash Flow | 499.00M | 543.00M | 667.00M | 274.00M | 260.00M | 246.00M |
| Investing Cash Flow | -197.00M | -253.00M | -229.00M | 484.00M | 347.00M | 166.00M |
| Financing Cash Flow | -401.00M | -502.00M | -271.00M | -1.27B | -770.00M | 393.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $5.42B | 11.90 | 9.51% | 3.03% | -3.12% | -8.23% | |
| ― | $2.94B | 9.68 | 23.16% | 0.25% | -4.03% | -39.51% | |
| ― | $6.92B | 9.40 | 47.08% | 1.27% | 2.70% | 15.17% | |
| ― | $9.52B | 46.96 | 3.66% | 1.15% | -2.12% | -69.42% | |
| ― | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
| ― | $2.61B | ― | -5.00% | 2.03% | -14.46% | -2170.83% | |
| ― | $1.96B | ― | -11.85% | ― | -3.00% | -447.89% |
On October 17, 2025, Adient US LLC and Adient plc, along with other loan parties, amended their existing revolving credit agreement with JPMorgan Chase Bank. The amendment extends the maturity date by five years and reduces the aggregate commitments to $1 billion, maintaining secured guarantees by the company and its subsidiaries.
The most recent analyst rating on (ADNT) stock is a Sell with a $20.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.
Adient plc reported strong business performance in the third quarter of fiscal year 2025, with improved earnings and margins compared to the previous year. The company generated solid free cash flow, enabling $50 million in additional share repurchases, and raised its revenue and adjusted EBITDA guidance for fiscal year 2025. Adient is well-positioned to benefit from onshoring trends in the U.S., with a significant portion of its North American production based domestically. The company continues to win diversified new business across all regions, particularly in EMEA and Asia, and remains focused on executing its strategic plans to drive shareholder value.
The most recent analyst rating on (ADNT) stock is a Hold with a $24.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.
Adient plc’s recent earnings call conveyed a positive sentiment, highlighting the company’s strong third-quarter performance. Despite facing challenges such as tariffs and commodity costs, Adient reported increased EBITDA and free cash flow, alongside significant new business wins and recognition for quality and customer service. The company also raised its guidance for the fiscal year, demonstrating confidence in its future prospects.
Adient plc is a global leader in automotive seating, operating over 200 manufacturing and assembly plants worldwide, and serving major original equipment manufacturers (OEMs) with complete seating systems and components.